Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Share News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.35
Bid: 4.20
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.30 (7.143%)
Open: 4.35
High: 4.35
Low: 4.35
Prev. Close: 4.35
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eden Research profit warning overshadows commercialisation deal

Wed, 21st Dec 2016 08:41

(ShareCast News) - As well as signing a commercialisation deal for its environmentally friendly pesticide with a US chemical giant, Eden Research warned on Wednesday that full year earnings would be lower than expected.AIM-listed Eden is transformed its business model from technology licensing to product sales, which it said had resulted in lower upfront payments, with the effect exacerbated by a delay in receiving regulatory approval in certain territories.Sales of its 3AEY plant protection product reaped more than €1m at distributor level, with over 85,000 litres sold, which was well above what Eden had forecast.The company issued financial guidance for the year, with revenue expected to be circa £0.4m, an EBITDA loss of roughly £1.1m with a net cash balance at the year end of around £1.4m.The company said it had signed an exclusive agreement with a subsidiary of Eastman Chemical, with which it has been working since 2014.Eastman will pay Eden an upfront fee, as well as annual milestone payments until 2019 when it is expected that sales will commence, and will also take on the responsibility for the registration of 'Cedroz' across 29 countries, including the largest markets for nematicide products globally.Chief executive Sean Smith said, "Eastman has been a leader in nematode control for several decades, and through their market development of Cedroz, they will extend this position and grow in the important post-fumigant nematode control market with an effective and safe bio-control product developed by Eden."Eastman's global reach and the robust, versatile and unique technology and formulation expertise that Eden has provided should produce a strong solution for growers challenged with the control of these pests that affect global agriculture by lowering crop yields."House broker Shore Capital had been forecasting revenue of £1.7m, EBITDA of £0.2m and net cash of £2.4m, and so after the statement said it was putting its forecasts under review."Overall, we believe the agreement with Eastman is encouraging as has been the performance of 3AEY during the year but the financial performance is disappointing," analysts said. "The underperformance is a function of the decision to evolve the operating model of the company which we presume is because of the enhanced returns on a longer term basis at the cost of the short term gains alongside slower than expected regulatory approvals. "Shares in Eden, having recently recovered close to six-month highs, fell 20% to 11.25p by Wednesday aftrernoon.
More News
23 Mar 2023 19:36

TRADING UPDATES: Regulatory wins for Eden; Marula AIM listing progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jan 2023 10:19

AIM WINNERS & LOSERS: RA International wins contract; Rosslyn plummets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
30 Jan 2023 10:05

Eden Research flagship biofungicide gains home authorisation in Italy

(Alliance News) - Eden Research PLC on Monday said its flagship product, Mevalone, has received authorisation for home and garden use in Italy.

Read more
10 Jan 2023 15:24

Eden Research set to beat expectations for revenue, losses

(Sharecast News) - Biopesticide and crop protection technology developer Eden Research said in an update on Tuesday that its revenue for 2022 was expected to have increased by 50% to £1.8m - £0.1m ahead of market expectations.

Read more
10 Jan 2023 11:59

IN BRIEF: Eden Research eyes annual revenue to be ahead of guidance

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - Expects revenue for the year ended on December 31 to be GBP1.8 million, ahead of market expectations of GBP1.7 million and up from GBP1.2 million a year earlier.

Read more
15 Dec 2022 21:39

TRADING UPDATES: Serinus completes rig-up; Xtract concludes JV deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Dec 2022 15:37

Eden Research inks distribution deal with Corteva France

(Sharecast News) - Biopesticides developer Eden Research has signed an agreement with Corteva France, it announced on Thursday, allowing Corteva to market, distribute and sell Eden's fungicide product 'Mevalone' in France on an exclusive basis.

Read more
2 Dec 2022 20:39

TRADING UPDATES: Sunrise secures funds; Bango launches e-distribution

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Oct 2022 21:55

EARNINGS SUMMARY: Eden Research, Fox Marble revenue up; LoopUp down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
26 Sep 2022 11:02

AIM WINNERS & LOSERS: musicMagpie wings clipped; US boost for Eden

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
26 Sep 2022 10:20

IN BRIEF: Eden Research shares surge on US EPA approval

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - Gets regulatory approval from the United States Environmental Protection Agency for all five petitions it submitted, covering three active ingredients and two formulated products. Ingredients are eugenol, geraniol and thymol, while the two products are Mevalone and Cedroz. Says the approval will bring "significant" revenue opportunities to the company, with total market potential of about EUR94 million for Mevalone and EUR189 million for Cedroz.

Read more
22 Aug 2022 10:59

IN BRIEF: Eden Research expects narrowed loss on interim revenue rise

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - For the first half of 2022, pretax loss is expected to narrow to GBP1.3 million from GBP1.8 million the year before, as revenue is expected to grow 33% year-on-year to GBP1.0 million from GBP800,000.

Read more
22 Aug 2022 09:48

Eden Research first-half loss set to narrow to £1.3m

(Sharecast News) - Biopesticides and animal health company Eden Research said in a trading update on Monday that it was expecting half-year revenue to have risen 33% year-on-year to £1m, adding that it was on track to meet its full-year guidance of £1.4m.

Read more
29 Jun 2022 21:29

TRADING UPDATES: Aquila closes acquisition; Mila's "impressive" assays

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
22 Jun 2022 15:48

UK shareholder meetings calendar - next 7 days

Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.